We are immensely glad to announce the Webinar on Endocrinology which is going to be held on January 03, 2024, with the theme "Endocrine Disruptors: Impact on Health and Well-being" The joy of attending Endocrinology 2024 brings with it improvement and incremental growth in your approach to doing things, in the broader manner to see things and the beauty to live international diversity. This Webinar gives an opportunity to network with your colleagues from across the globe exchange ideas with expertise and arm yourself with the latest information. Our Webinar will introduce sessions that will feature leading-edge displays, special panel discussions, and livelier interaction with Endocrinology specialists from across the globe.
Session 1: Obesity and Metabolic Syndrome
Obesity occurs when a man's muscle mass exceeds his fat mass to the point where it threatens his health. A man is considered corpulent if his body weight is at least 20% more than it should be. If your Body Mass Index (BMI) is between 25 and 29.9, you are considered overweight. If your BMI is 30 or over, you are considered overweight. Diabetes mellitus is a chronic, long-term disease that affects your body's ability to utilize the energy available in food. Type 1 diabetes, type 2 diabetes, and gestational diabetes are the three types of diabetes to be aware of. Something similar can be found in a wide variety of diabetes mellitus. Normally, your body converts the sugars and carbs you consume into a single sugar known as glucose.
Session 2: Endocrinology and Metabolic Disorder
Endocrine diseases influence the body's ability to digest certain nutrients and vitamins, whereas metabolic disorders affect the body's ability to over- or under-produce certain hormones. Hypothyroidism, congenital adrenal hyperplasia, parathyroid gland diseases, diabetes mellitus, adrenal gland diseases (including Cushing's syndrome and Addison's disease), and ovarian dysfunction (including polycystic ovary syndrome) are among the endocrine disorders. The study of hormone processes and neuroendocrine systems that influence or govern behaviour is known as behavioural endocrinology. Endocrinology is a broad field that impacts not just our endocrine system but also our skin, implying that dermatology is involved indirectly.
Session 3: Pre-Diabetes and Cardiovascular Diseases
A diagnosis of prediabetes should serve as a wake-up call to patients to undertake lifestyle adjustments that will help them avoid full-blown diabetes and cardiovascular disease (CVD). We know that having diabetes raises the risk of acquiring cardiovascular disease, therefore we wanted to see what the absolute risk or probability of developing heart disease was for those with blood sugar levels that were only slightly higher than pre-diabetic. A fasting blood sugar level of 100 to 125 mg/dL (5.6 to 6.9 mmol/L) indicates prediabetes, but a fasting blood sugar level of less than 100 mg/dL (5.6 mmol/L) is considered normal. The diagnostic threshold for diabetes is 126 mg/dL (7 mmol/L) or higher.
Session 4: Thyroid Disease
Thyroid disease and diabetes are both endocrine and hormone disorders. Thyroid dysfunction can make blood glucose control more challenging in those who have diabetes. It's not unusual for someone to have thyroid problems and diabetes at the same time. Thyroid disease is more likely to occur if you have type 1 diabetes, type 2 diabetes, insulin resistance, or metabolic syndrome. Thyroid illness also raises the risk of metabolic syndrome and type 2 diabetes. If you are overweight or obese, this link is considerably stronger. Many of your body's basic activities, such as growth, development, and metabolism, are regulated by your thyroid gland and thyroid hormones. Thyroid disease might affect your blood sugar levels because it interferes with metabolism. This increases your risk of acquiring diabetes and makes managing your blood sugar more difficult if you already have it.
Session 5: Osteoporosis Health Care
Osteoporosis is a global age-related health concern that affects both male and female senior people. It slowly deteriorates the microstructure of bone, especially at trabecular locations like vertebrae, ribs, and hips, leading to fragility fractures, pain, and disability. Diabetes mellitus (DM), particularly type 1 DM, leads to and/or aggravates bone loss in osteoporotic patients, despite the fact that osteoporosis is generally associated with ageing and oestrogen shortage. This subject spotlight article covers DM-induced osteoporosis and DM/osteoporosis comorbidity, as well as changes in bone metabolism and hormones that regulate bone formation in diabetic patients, such as insulin, insulin-like growth factor-1, and angiogenesis. Also covered are the cellular and molecular processes of DM-related bone loss. This knowledge lays the groundwork for a better understanding of diabetes complications as well as the development of early osteoporosis screening and prevention in diabetic patients.
Session 6: Diet and Physical Activity
The importance of good nutrition in diabetes management cannot be overstated. You have the best chance of preventing diabetes if you eat the correct foods and engage in other lifestyle behaviours that promote healthy blood sugar and insulin levels. Curcumin and berberine are two herbs that may help raise insulin sensitivity and lessen the chance of diabetes progression. The main goal of type 1 and type 2 diabetes treatment is to keep blood sugar (glucose) levels within acceptable limits. Insulin, exercise, and a healthy diet are used to treat type 1 diabetes. When weight loss, a type 2 diabetes diet, and exercise fail to control the increased blood sugars of type 2 diabetes, diabetes medicines (oral or injectable) are prescribed. If other drugs are ineffective, insulin treatment may be started.
Session 7: Wound Care and Management
Diabetic patients' wound healing slows down due to a variety of causes, including diabetes. High glucose levels (When your glucose level is greater than normal, it prevents nutrients and oxygen from reaching cells, preventing your immune system from functioning properly and, in the long run, causing aggravation in the body's cells.) (Neuropathy) is the damage caused to nerve cells as a result of persistently elevated glucose levels. This could result in a loss of sensation in the affected areas. Diabetic individuals' hands and feet are commonly affected. When it occurs, one will be unable to feel wounds when they happen. This is one noteworthy motivation behind why foot wounds tend to be more typical in individuals with diabetes.
The endocrinology drugs market size is expected to grow by USD 36.55 billion from 2022 to 2027. In addition, the momentum of the market will be progressing at a CAGR of over 7.82% during the forecast period, according to Technavio Research. The market is segmented by distribution channel (Hospital pharmacies, Retail pharmacies, and Online pharmacies), therapy area (diabetes drugs, HGH, thyroid hormone, others), and geography (North America, Europe, Asia, and Rest of World (ROW)). North America is estimated to contribute 45% to the growth of the global market. The North American market is expected to have a rapid growth momentum due to the aging population, increasing the risk of endocrine disorders. The high prevalence of diabetes, the most common endocrine disorder, is the main revenue driver for the regional market. Furthermore, patient education initiatives by organizations such as the American Diabetes Association and the American Association of Diabetes Educators are also driving market growth in the region. In addition, training programs conducted by the CDC and the National Institute of Diabetes, Digestive, and Kidney Diseases for healthcare professionals are expected to drive the market growth during the forecast period. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment.
Technavio has announced its latest market research report titled Global Endocrinology Drugs Market 2023-2027
Meetings Int. is a worldwide pioneer in delivering top-notch gatherings, workshops, and symposia in every significant field of science, innovation, and medication worldwide receiving 400,000+ online visitors with 1000+ sessions which confirms an outstanding pool of new users and visitors creating a platform to build your market place globally. Since its initiation, Meetings Int. has been related to national and global affiliations, organizations, and elevated-level people, committed to having world-class meetings and occasions so it provides a big platform to show your product and advertising. The explorer’s traffic is the benchmark for advertisement, and the Breast Cancer website is continually dragged worldwide. As specified by Google Analytics, in excess of 12,836 researchers and industrials are visiting our conference sites. The Endocrinology 2024 virtual seminar helps you put the spotlight on your brand by advertising with more than 9 million+ readers worldwide about 5 million+ hits every month on our site. We provide an excellent opportunity to boost your business on our platform. We offer a range of eye-catching advertising spaces and branding. Researchers from powerful nations including the United States, Japan, United Kingdom, India, France, Taiwan, and Germany, etc. Visit our conference site. Subscribers and conference attendees can be your upcoming enthusiastic customers. We maintain high quality and ethical standards in the event industry, which makes us unique and better than the rest. Advertisement banners must be provided by the advertising company and in jpg or jpeg format. The banner must be of high resolution and must not have copyright infringement.
